Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Cancer-Related Fatigue: Meta-Analysis Identifies Effective Treatments

      April 6, 2017
      By Lisa Schulmeister, RN, MN, APRN-BC, FAAN
      Article

      A recent meta-analysis found that the most effective treatments for cancer-related fatigue are exercise and psychological interventions.

      People undergoing cancer treatment frequently report fatigue, which can range from somewhat bothersome to debilitating. Although the body of research on treatments for fatigue is growing, most studies are single institution studies evaluating 1 type of treatment.

      Researchers from six healthcare institutions around the United States performed a meta-analysis of research on cancer-related fatigue (CRF). They compared the mean weighted effect sizes of the four most commonly recommended treatments for CRF (exercise, psychological, combined exercise and psychological, and pharmaceutical) and identified independent variables associated with treatment effectiveness.

      Among 17,033 references, 113 unique studies with over 11,000 participants had sufficient data to be included in the meta-analysis. Exercise, psychological interventions, and exercise plus psychological interventions improve CRF during and after primary cancer treatment; however, pharmacologic interventions did not show improvement in CRF. Results also suggest that CRF treatment effectiveness was associated with cancer stage, baseline treatment status, treatment delivery mode, and fatigue measures.

      The researchers concluded that exercise and psychological interventions are effective for reducing CRF during and after cancer treatment, and they are significantly better than the available pharmaceutical options. They recommend exercise or psychological interventions as first-line treatments for CRF. The study findings are available here.

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      Photo of a man wearing a suit in front of an Oncology Nursing News backdrop
      Photo of a man wearing a suit in front of an Oncology Nursing News backdrop
      Photo of a woman with shoulder-length brown hair with a maroon shirt and black blazer
      Related Content

      Diagram of endometrial cancer

      Rx Road Map: Durvalumab for Endometrial Cancer

      Abigail T. Ramontal, MHP, MSN, APRN-FP-C
      September 12th 2025
      Article

      The Vitals

      Nicole Gay Shares How She Counsels Patients on Lung Cancer Screenings

      Lindsay Fischer
      September 12th 2025
      Podcast

      Photo of a woman with blond hair in front of a greenery background

      Opinion: Nursing Considerations for Emerging CLDN6-Targeted Therapies

      Amanda Brink, DNP, APRN, FNP-BC, AOCNP
      September 12th 2025
      Article

      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Lindsay Fischer
      September 12th 2025
      Podcast

      Colorectal cancer

      Nurses Are Key to Reducing Opioid Use After Colorectal Surgery

      Bridget Hoyt
      September 12th 2025
      Article

      Photo of a woman with blonde hair wearing a white and black blazer

      Managing CRS in Hematologic Cancers: A Nursing Perspective

      Gina Mauro
      September 12th 2025
      Article
      Related Content

      Diagram of endometrial cancer

      Rx Road Map: Durvalumab for Endometrial Cancer

      Abigail T. Ramontal, MHP, MSN, APRN-FP-C
      September 12th 2025
      Article

      The Vitals

      Nicole Gay Shares How She Counsels Patients on Lung Cancer Screenings

      Lindsay Fischer
      September 12th 2025
      Podcast

      Photo of a woman with blond hair in front of a greenery background

      Opinion: Nursing Considerations for Emerging CLDN6-Targeted Therapies

      Amanda Brink, DNP, APRN, FNP-BC, AOCNP
      September 12th 2025
      Article

      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Lindsay Fischer
      September 12th 2025
      Podcast

      Colorectal cancer

      Nurses Are Key to Reducing Opioid Use After Colorectal Surgery

      Bridget Hoyt
      September 12th 2025
      Article

      Photo of a woman with blonde hair wearing a white and black blazer

      Managing CRS in Hematologic Cancers: A Nursing Perspective

      Gina Mauro
      September 12th 2025
      Article

      Latest Conference Coverage

      Safety Management With Amivantamab Plus Lazertinib in NSCLC

      Tepotinib Shows Manageable Safety in MET Exon 14+ NSCLC

      Adverse Events of Menin Inhibitors in AML: What Nurses Should Know

      Ivonescimab/Chemo Ups PFS After Third-Generation TKI in EGFR+ NSCLC

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      259 Prospect Plains Rd, Bldg H,
      Monroe, NJ 08831

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.